Xiang Yang Zhang, MD, PhD

Depression, Rumination, and Suicide Attempts in Adolescents With Mood Disorders: Sex Differences

June 19, 2024

The authors found that in male adolescents, suicide attempts are mostly influenced by depressive symptoms. In female adolescents, depressive symptoms not only directly increase the risk of suicide attempts,...

Dianying Liu , Gang Lei , Dian Li , et al

Original Research

Weight Gain and Antipsychotic Treatment Response

May 11, 2021

How does weight gain during antipsychotic treatment relate to therapeutic response? This 8-week study investigates the question.

Xiang Yang Zhang , Mei Hong Xiu , Ying Qi Chen , et al

Original Research

Suicide and Cognition in Schizophrenia

July 24, 2018

Although chronic schizophrenia has been linked to elevated rates of suicide, data on suicide rates in first-episode schizophrenia are scarce. Read this article to learn the rate of suicide...

Jair C. Soares , Xiang Yang Zhang , Xiangdong Du , et al

Original Research

BDNF Variants and Cognition in Schizophrenia

August 24, 2016

Can a genetic susceptibility to schizophrenia be identified? Examine the role that specific polymorphisms of the BDNF gene may have in development of schizophrenia and in cognitive function in...

Jair C. Soares , Xiang Yang Zhang , Da Chun Chen , et al

Original Research

Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia

March 23, 2016

Jair C. Soares , Xiang Yang Zhang , Li Hui , et al

Original Research

Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia: A Voxel-Based Diffusion Tensor Imaging Study

February 24, 2016

Jair C. Soares , Thomas R. Kosten , Xiang Yang Zhang , et al

Original Research

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

April 15, 2013

Thomas R. Kosten , Xiang Yang Zhang , Li Hui , et al

Article

Gender Differences in Never-Medicated First-Episode Schizophrenia and Medicated Chronic Schizophrenia Patients

July 15, 2012

Fu De Yang , Thomas R. Kosten , Xiang Yang Zhang , et al

Letter to the Editor

Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

July 21, 2009

Jing Xu Chen , Yun Ai Su , Shao Li Wang , et al

Original Research

Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia

May 15, 2007

Thomas R. Kosten , Xiang Yang Zhang , Yun Long Tan , et al

Original Research

Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol: Relationship to Outcome in Schizophrenia

July 1, 2004

Xiang Yang Zhang , Dong Feng Zhou , Lian Yuan Cao , et al

Original Research

A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia

November 1, 2001

Xiang Yang Zhang , Dong Feng Zhou , Lian Yuan Cao , et al

Depression, Rumination, and Suicide Attempts in Adolescents With Mood Disorders: Sex Differences

Weight Gain and Antipsychotic Treatment Response

Suicide and Cognition in Schizophrenia

BDNF Variants and Cognition in Schizophrenia

Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia

Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia: A Voxel-Based Diffusion Tensor Imaging Study

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

Gender Differences in Never-Medicated First-Episode Schizophrenia and Medicated Chronic Schizophrenia Patients

Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia

Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol: Relationship to Outcome in Schizophrenia

A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia

ELSEWHERE:

FOLLOW US:

Xiang Yang Zhang, MD, PhD

Depression, Rumination, and Suicide Attempts in Adolescents With Mood Disorders: Sex Differences

Weight Gain and Antipsychotic Treatment Response

Suicide and Cognition in Schizophrenia

BDNF Variants and Cognition in Schizophrenia

Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia

Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia: A Voxel-Based Diffusion Tensor Imaging Study

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

Gender Differences in Never-Medicated First-Episode Schizophrenia and Medicated Chronic Schizophrenia Patients

Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia

Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol: Relationship to Outcome in Schizophrenia

A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles